35. Psoriasis

Impact of Chronic Skin Diseases on Male Sexual Function in Upper Egypt

Hatem Kamal Abdel Hafez Abdel Hafez, Amira Ali Abdel Motaleb Abdel Motaleb, Hisham Diab Gaber Gaber

Netakimab: 12-week results from PLANETA study, a phase III trial of a novel IL-17 inhibitor in moderate-to-severe plaque psoriasis

Bakulev Andrey, Samtsov Aleksey, Artemeva Antonina, Chernyaeva Ekaterina, Ivanov Roman

Guselkumab Demonstrates Greater Efficacy Compared to Secukinumab Across Body Weight Quartiles and Body Mass Index Categories: Week 48 Results From the ECLIPSE Trial

April Armstrong, Andrew Blauvelt, Susan Flavin, Ming-chun Hsu, Bruce Randazzo, Kristian Reich, Richard Langley

Secukinumab Treatment Leads to Normalization of Quality of Life of Patients with Psoriasis and Psoriatic Arthritis with and without Previous Systemic Therapy: Results from the PROSE Study

Matthias Augustin, Esteban Dauden Tello, Ulrich Mrowietz, Carle Paul, Sascha Gerdes, Michael Rissler, Sven Gathmann, Christian Sieder, Teresa Bachuber, Roberto Orsenigo

Efficacy and Safety of Continuous Q12W Risankizumab Versus Treatment Withdrawal: 104-Week Results from the Phase 3 IMMhance Trial

Andrew Blauvelt Blauvelt, Craig Leonardi Leonardi, Melinda Gooderham Gooderham, Kim Papp Papp, Sandra Philipp Philipp, Jashin J. Wu Wu, Atsuyuki Igarashi Igarashi, Mary Flack Flack, Ziqian Geng Geng, Tianshuang Wu Wu, Anne Camez Camez, David Williams Williams, Richard G. Langley Langley

SNA-120, A Novel Topical Non-steroidal Therapy for Psoriasis and Associated Pruritus that Targets the NGF/TrkA Pathway: Results from a Multicenter Phase 2b Study

Kristina Callis Duffin, Sonja Ständer, Zoe Draelos, Gurpreet Ahluwalia, Paul Lizzul

Patients with psoriasis and psoriatic arthritis: comorbidities from dermatological clinical practice.

Maria Chamurlieva

Ixekizumab for the treatment of moderate to severe psoriasis in patients with comorbidities and/or previous failure of conventional and biologic therapies: an italian real-life experience

Catia De Felice, Dario Graceffa, Roberta Capoccia, Aldo Morrone, Claudio Bonifati

Metagenomic analysis of the human gut microbiome in non-treated plaque psoriasis patients

Ignacio Dei-cas, Florencia Giliberto, Alberto Penas Steinhardt

Secukinumab efficacy without the initial loading dose in patients with chronic plaque psoriasis

Paolo Gisondi, Marco Rovaris, Stefano Piaserico, Enrico Costa, Silvia Manfrè, Giampiero Girolomoni

A comparative study of the efficacy and safety of oral apremilast versus oral methotrexate in patients with moderate to severe chronic plaque psoriasis

Saumya Goel Goel

Discontinuation of anti-TNF therapy in Patients with PsA. Preliminary data from a clinical and ultrasonographic study.

Dario Graceffa, Catia De Felice, Viviana Lora, Fulvia Elia, Francesco Maria Solivetti, Aldo Morrone, Claudio Bonifati

A preclinical study of human amnion-derived mesenchymal stem cells in mouse model of psoriasis

Hideki Hayashi, Yasutomo Imai, Kenichi Yamahara, Akiko Hamada, Yoshihiro Fujimori, Kiyofumi Yamanishi

Does psoriasis with joint pain always means psoriasis arthritis? A rare case report

Suchun Hou Hou, Yuan Li Li, Xiaohong Chen Chen, Yuhong Zhang Zhang, Li Ma Ma, Bin Wang Wang, Xiaoming Liu Liu

A case report of severe recalcitrant psoriasis treated with Itolizumab: a novel anti-CD6 monoclonal antibody

Shrea Kapoor, Aayush Gupta

A placebo-controlled, randomized trial to assess, using PET scan, systemic and vascular inflammation, and response to therapy, in patients with psoriasis

Sharonjeet Kaur, Nusrat Shafiq, Sunil Dogra, Br Mittal, Ajay Bahl, Tarun Narang, Samir Malhotra

A CLINICO-ETIOLOGICAL STUDY OF SCALING SCALP

Sruthi Kondaveeti, Venkata Satya Bhaskara Rama Murthy Damaraju

Palmoplantar pustulosis with Pyoderma gangrenosum with Behcet’s disease: A triple whammy!!

Sayli Korde

Secukinumab Treatment Normalizes Inflammatory Markers and Immune Response and Leads to Clinical Improvement in Patients With Psoriasis: Findings From the Primary Analysis of the ObePso-S Study

James Krueger, David Pariser, Patricia Lee, Jerry Bagel, April Armstrong, Elisa Muscianisi, Farid Kianifard, Rajendra Sarkar, Jennifer Steadman, Andrew Blauvelt

Successful treatment of pustular psoriasis with Itolizumab a novel CD6 blocking antibody in 3 cases.

Mahendra Kura, Avinash Sajgane, Maina Hegde

Secukinumab provides comprehensive long-term treatment across multiple manifestations of psoriatic disease

Richard Langley, Kristian Reich, Robert Bissonnette, Alice Gottlieb, Helena Marzo-ortega, Gabriele Dicomite, Maher Aassi, Philip Mease

Ixekizumab Demonstrates High Sustained Efficacy and a Favorable Safety Profile in Patients with Moderate-to-Severe Psoriasis through Five Years of Treatment

Craig Leonardi, Peter Foley, Hideshi Torii, Sascha Gerdes, Hany Elmaraghy, Gaia Gallo, David Shrom, Ann Leung, Kim Papp

A Case Of Psoriasis Vulgaris Treated With Secukinumab

Wahyu Lestari Lestari, Mimi Maulida Maulida, Nanda Earlia Earlia, Sitti Hajar Hajar, Fitria Fitria

The prevalence of John Cunningham (JC) virus antibody positivity in psoriasis patients.

Oonagh Molloy, Anna Malara, Jaythoon Hassan, Maeve Lynch, Julianne Clowry, Irene Tmoney, Aoife Lally, Blaithin Moriarty, Paul Collins, Rosalind Hughes, Cillian De Gascun, Brian Kirby

Effecacy of oral methotrexate monotherapy versus oral methotrexate plus narrrowband UV-B phototherapy in recalcitrant palmo plantar psoriasis

Mohammad Rafiqul Mowla Mowla, Shamim Ara Shamima

Knowledge, Attitudes and Adherence to the Guidelines among Dermatologists Regarding the Use of Biologic Agents to Manage Psoriasis: A Cross Sectional Survey of Dermatologists in Iran

Robati Reza, Almasi-nasrabadi Mina, Zargari Omid

Prospective controlled pilot study analysing the value of an educational program and a psoriasis app for psoriasis patients.

Theresa Schulze-hagen, Lena Domogalla, Johannes Benecke, Astrid Schmieder

ANTI-INFLAMMATORY EFFECT OF THE APPLICATION OF SELENIUM WITH THE PHILIFORM SHOWER TO PATIENTS WITH PSORIASIS IN THE THERMAL CENTER OF LA ROCHE POSAY-FRANCIA

Romina Valeria Verde, Maria Lorena Vela, Evelyne Delrez, Flavia Persechino, Domenico Giordano, Rachid Ainoche, Severino Persechino, Alejandra Valeria Lepore

Granulysin-positive NK cells form the part of cytotoxicity pathway in the pathogenesis of psoriasis

Marijana Vicic, Vlatka Sotosek Tokmadzic, Marija Kastelan, Ines Brajac, Larisa Prpic Massari

MITOCHONDRIAL FUNCTION IN PSORIASIS AND INSULIN RESISTANCE: A PILOT STUDY

Alejandra Villarreal Martinez, Sonia Chavez Alvarez, Jesus Ancer Arellano, Minerva Gomez Flores, Jorge Ocampo Candiani, Consuelo Ruiz Herrera, Maria Del Rosario Torres Sepulveda, Laura Elia Martinez De Villarreal

Dynamin-related protein 1 is a novel biomarker and treatment target for psoriasis

Zuyi Weng, Juan Li

Association between tofacitinib-based therapy and cardiovascular events in patients with chronic plaque psoriasis: a systematic review and meta-analysis of randomized controlled trials

Wenhui Xie, Zhuoli Zhang Zhang

Dose optimization of brodalumab in moderate-to-severe plaque psoriasis

Jensen Yeung, Matthew Ladda, Vincent Piguet

The coexistence of psoriasis and vitiligo：by chance, or for a reason?

Qian Zhao, Baozhen Lu, Changhua Liu, Yuzhen Li, Bingxue Bai